Cathérine Gebhard, chair of the scientific programme management of the CAS, published a review on the impact of sex and gender on COVID-19 outcomes in Europe. In collaboration with Sabra Klein, Vera Regitz-Zagrosek, Rosemary Morgan, and Hannelore Neuhauser she discusses potential sex-specific mechanisms modulating the course of disease. The article is published in “Biology of Sex Differences”: https://rdcu.be/b4sMZ
Prof. Dr. med. Dr. sc. nat. Cathérine Gebhard, chair of the course directors of the CAS in Sex- and Gender-Specific Medicine, investigates the impact of Sex and Gender on COVID-19 outcomes. The Swiss National Foundation supports the project “Impact of Sex and Gender on COVID-19 outcomes: Role of ACE-2, TMPRSS2, and gender-specific risk factors” (Project), submitted by Gebhard together with Prof. Dr. med. Beatrice Beck Schimmer, one of the initiators of the CAS, CAS-lecturer Prof. Dr. med. Dr. h.c. Vera Regitz and colleagues.
The gender disparities observed in COVID-19 vulnerability clearly emphasize the need to understand the impact of sex and gender on incidence and case fatality of the disease so that treatment in highly vulnerable demographic groups can be timely and tailored to their specific needs. The project will combine clinical data from ongoing cohort studies with retrospective experimental work in mice with. This strategy allows rapid analysis of data and implementation of results. The work will identify both, biological sex- and gender-related predictors of severe variants of COVID-19 and has the potential to contribute to the identification of effective antiviral interventions.
The module “Introduction to Gendermedicine” will take place next year on 10-11 March 2021. Further course dates will be announced continuously.
Given the current situation regarding the new coronavirus we have come to the conclusion that the implementation of the CAS is currently not possible within the desired framework. Since networking and personal exchange of experiences and opinions are an important part of the CAS, we also do not want to conduct the continuing education course online.
Therefore, we have decided to postpone the start of the CAS in Sex- and Gender-Specific Medicine until March 2021. The exact dates of the individual modules will be announced as soon as possible.
Five partially sponsored places are available for the first cohort of the CAS. The program covers 5,000 Swiss francs, and participants must pay the remaining 4,400 Swiss francs. If you are applying for such a place, please explain in your application how you
- want to apply the acquired knowledge in your professional life.
- can act as “ambassador” to increase awareness of gender specific medicine in science and medicine.
If you are interested, please register here.
PhD students receive a 50 percent discount for the entire CAS as well as for the individual modules (please apply under Comments when registering). The costs for PhD students are CHF 4’700 for the whole CAS and CHF 480 for each individual module.
It is possible to complete the CAS in Sex- and Gender- Specific Medicine over two years and to attend individual modules in the second year.
If you are interested, please register here.
The CAS in Sex- and Gender-Specific Medicine is mentioned in an article about professor Vera Regitz-Zagrosek in the European Heart Journal:
“Another important project for Vera is her contribution to the certificate of advanced studies (CAS) for ‘Sex- and Gender-Specific Medicine’ of the universities of Bern and Zurich. This CAS initiated by Professor Daniel Candinas, Vice-Rector for Research of the Universityof Bern and Professor Beatrice Beck Schimmer will be open for post-graduate students from various fields. The program is coordinated by Professor Cathérine Gebhard, professor for cardiovascular gender-specific medicine and cardiac imaging at Zurich University and the University Hospital Zurich. The course modules include cardiovascular medicine, endocrinology and metabolism, sex- and gender-specific study design, neurology and psychiatry, pharmacology, public health,and other topics. The curriculum teaches a broad and comprehensive spectrum in gender-specific medicine. The start is envisioned for May 2020.”
After a long and intensive preparation period, the registration for the first CAS further education course in Sex- and Gender-Specific Medicine in Switzerland can finally start. Registration for the CAS or for individual modules is now open.
*Subject to the approval of the university management and the extended university management of the University of Zurich.